Recombinant ApxIV protein enhances protective efficacy against Actinobacillus pleuropneumoniae in mice and pigs.

MLA

Wu, H. C., et al. “Recombinant ApxIV Protein Enhances Protective Efficacy against Actinobacillus Pleuropneumoniae in Mice and Pigs.” Journal of Applied Microbiology, vol. 124, no. 6, June 2018, pp. 1366–76. EBSCOhost, https://doi.org/10.1111/jam.13726.

APA

Wu, H.-C., Yeh, P.-H., Hsueh, K.-J., Yang, W.-J., & Chu, C.-Y. (2018). Recombinant ApxIV protein enhances protective efficacy against Actinobacillus pleuropneumoniae in mice and pigs. Journal of Applied Microbiology, 124(6), 1366–1376. https://doi.org/10.1111/jam.13726

Chicago

Wu, H-C, P-H Yeh, K-J Hsueh, W-J Yang, and C-Y Chu. 2018. “Recombinant ApxIV Protein Enhances Protective Efficacy against Actinobacillus Pleuropneumoniae in Mice and Pigs.” Journal of Applied Microbiology 124 (6): 1366–76. doi:10.1111/jam.13726.